Zdrowie i gospodarka · 30/06/2026

FDA Classifies Skin Patch for Hyperhidrosis into Class II with Special Controls

The FDA has classified the skin patch for treating hyperhidrosis into Class II, a category that requires special controls to ensure safety and effectiveness, aiming to enhance patient access to innovative devices while reducing regulatory burdens.